Treatment of cocaine cardiovascular toxicity: a systematic review

References

• United Nations Office on Drugs and Crime (UNODC). World Drug Report 2014; [cited 2015 Nov 1]. Available from: http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. 2011: National estimates of drug-related emergency department visits; [cited 2015 Nov 1]. Available from: http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm.
   Google Scholar
• U.S. Department of Justice Drug Enforcement Agency. National Drug Threat Assessment Summary; [cited 2015 Nov 1]. Available at: https://info.publicintelligence.net/DEA-DrugThreats-2014.pdf.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. [cited 2015 Nov 1]. Available from: http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm.
   Google Scholar
• Chang G, Weiss AP, Orav EJ, et al. Predictors of frequent emergency department use among patients with psychiatric illness. Gen Hosp Psychiatry. 2014;36:716–720.
   PubMed Web of Science ®Google Scholar
• Cunningham R, Walton MA, Weber JE, et al. One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain. Ann Emerg Med. 2009;53:310–320.
   PubMed Web of Science ®Google Scholar
• Bernstein J, Bernstein E, Shepard DS, et al. Racial and ethnic differences in health and health care: lessons from an inner-city patient population actively using heroin and cocaine. J Ethn Subst Abuse. 2006;5:35–50.
   PubMedGoogle Scholar
• Zimmerman JL. Cocaine intoxication. Crit Care Clin. 2012;28:517–526.
   PubMed Web of Science ®Google Scholar
• Cain MA, Bornick P, Whiteman V. The maternal, fetal, and neonatal effects of cocaine exposure in pregnancy. Clin Obstet Gynecol. 2013;56:124–132.
   PubMed Web of Science ®Google Scholar
• Freeman K, Feldman JA. Cocaine, myocardial infarction, and beta-blockers: time to rethink the equation? Ann Emerg Med. 2008;51:130–134.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Oxford Centre for Evidence-Based Medicine Levels of Evidence Working Group. OECBM Levels of Evidence System; [cited 2015 Nov 1]. Available from: http://www.cebm.net/index.aspx?o=5653.
   Google Scholar
• ACCF/AHA Task Force on Practice Guidelines. Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines; [cited 2015 Nov 1]. Available from: http://assets.cardiosource.com/Methodology_Manual_for_ACC_AHA_Writing_Committees.pdf.
   Google Scholar
• Forster A, Gardaz JP, Suter PM, et al. Respiratory depression by midazolam and diazepam. Anesthesiology. 1980;53:494–497.
   PubMed Web of Science ®Google Scholar
• Short TG, Forrest P, Galletly DC. Paradoxical reactions to benzodiazepines-a genetically determined phenomenon? Anaesth Intensive Care. 1987;15:330–331.
   PubMed Web of Science ®Google Scholar
• Agelink MW, Majewski TB, Andrich J, et al. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med. 2002;30:997–1006.
   PubMed Web of Science ®Google Scholar
• Baumann BM, Perrone J, Hornig SE, et al. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med. 2000;7:878–885.
   PubMed Web of Science ®Google Scholar
• Haga JL, Baker RW, Rush CR. Behavioral and physiological effects of cocaine in humans following triazolam. Pharmacol Biochem Behav. 2003;76:383–392.
   PubMed Web of Science ®Google Scholar
• Honderick T, Williams D, Seaberg D, et al. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med. 2003;21:39–42.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Poling J, Mitchell E, et al. Tiagabine affects the subjective responses to cocaine in humans. Pharmacol Biochem Behav. 2005;82:569–573.
   PubMed Web of Science ®Google Scholar
• Richards JR, Derlet RW, Duncan DR. Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol. J Emerg Med. 1998;16:567–573.
   PubMedGoogle Scholar
• Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88:325–331.
   PubMed Web of Science ®Google Scholar
• Daras M, Kakkouras L, Tuchman AJ, Koppel BS. Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome? Acta Neurol Scand. 1995;92:161–165.
   PubMed Web of Science ®Google Scholar
• Chase PB, Biros MH. A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population. Acad Emerg Med. 2002;9:1402–1410.
   PubMed Web of Science ®Google Scholar
• Drake TR, Henry T, Marx J, et al. Severe acid-base abnormalities associated with cocaine abuse. J Emerg Med. 1990;8:331–334.
   PubMed Web of Science ®Google Scholar
• Riggs D, Weibley RE. Acute toxicity from oral ingestion of crack cocaine: a report of four cases. Pediatr Emerg Care. 1990;6:24–26.
   PubMedGoogle Scholar
• Merigian KS, Park LJ, Leeper KV, et al. Adrenergic crisis from crack cocaine ingestion: report of five cases. J Emerg Med. 1994;12:485–490.
   PubMedGoogle Scholar
• Hassan TB, Pickett JA, Durham S, et al. Diagnostic indicators in the early recognition of severe cocaine intoxication. J Accid Emerg Med. 1996;13:261–263.
   PubMedGoogle Scholar
• Brady WJ, Chan TC. Electrocardiographic manifestations: benign early repolarization. J Emerg Med. 1999;17:473–478.
   PubMed Web of Science ®Google Scholar
• Wang RY. pH-dependent cocaine-induced cardiotoxicity. Am J Emerg Med. 1999;17:364–369.
   PubMed Web of Science ®Google Scholar
• Somers MP, Brady WJ, Perron AD, et al. The prominent T wave: electrocardiographic differential diagnosis. Am J Emerg Med. 2002;20:243–251.
   PubMed Web of Science ®Google Scholar
• Jonsson S, O'Meara M, Young JB. Acute cocaine poisoning. Importance of treating seizures and acidosis. Am J Med. 1983;75:1061–1064.
   PubMed Web of Science ®Google Scholar
• Chiu YC, Brecht K, DasGupta DS, et al. Myocardial infarction with topical cocaine anesthesia for nasal surgery. Arch Otolaryngol Head Neck Surg. 1986;112:988–990.
   PubMedGoogle Scholar
• Gay GR, Loper KA. The use of labetalol in the management of cocaine crisis. Ann Emerg Med. 1988;17:282–283.
   PubMed Web of Science ®Google Scholar
• Lombard J, Wong B, Young JH. Acute renal failure due to rhabdomyolysis associated with cocaine toxicity. West J Med. 1988;148:466–468.
   PubMedGoogle Scholar
• Jandreski MA, Bermes EW, Leischner R, et al. Rhabdomyolysis in a case of free-base cocaine (“crack”) overdose. Clin Chem. 1989;35:1547–1549.
   PubMed Web of Science ®Google Scholar
• Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia. N Engl J Med. 1992;327:361.
   PubMed Web of Science ®Google Scholar
• Merigian KS. Cocaine-induced ventricular arrhythmias and rapid atrial fibrillation temporally related to naloxone administration. Am J Emerg Med. 1993;11:96–97.
   PubMed Web of Science ®Google Scholar
• Kerns W II, Garvey L, Owens J. Cocaine-induced wide complex dysrhythmia. J Emerg Med. 1997;15:321–329.
   PubMedGoogle Scholar
• Weiner AL, Bayer MJ, McKay CA Jr, et al. Anticholinergic poisoning with adulterated intranasal cocaine. Am J Emerg Med. 1998;16:517–520.
   PubMed Web of Science ®Google Scholar
• Tanen DA, Graeme KA, Curry SC. Crack cocaine ingestion with prolonged toxicity requiring electrical pacing. J Toxicol Clin Toxicol. 2000;38:653–657.
   PubMed Web of Science ®Google Scholar
• Chan GM, Sharma R, Price D, et al. Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS). J Med Toxicol. 2006;2:108–111.
   PubMedGoogle Scholar
• Bebarta VS, Summers S. Brugada electrocardiographic pattern induced by cocaine toxicity. Ann Emerg Med. 2007;49:827–829.
   PubMed Web of Science ®Google Scholar
• Fareed FN, Chan G, Hoffman RS. Death temporally related to the use of a Beta adrenergic receptor antagonist in cocaine associated myocardial infarction. J Med Toxicol. 2007;3:169–172.
   PubMedGoogle Scholar
• Kalimullah EA, Bryant SM. Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest – treatment nuances and controversies. J Med Toxicol. 2008;4:277–283.
   PubMedGoogle Scholar
• Hantson P, Capron A, Wallemacq P. Toxicokinetics of cocaine and metabolites in a body-packer becoming symptomatic. J Forensic Leg Med. 2011;18:385–387.
   PubMed Web of Science ®Google Scholar
• Javed F, Benjo AM, Reddy K, et al. Dexmedetomidine use in the setting of cocaine-induced hypertensive emergency and aortic dissection: a novel indication. Case Rep Med. 2011;2011:174132.
   PubMedGoogle Scholar
• Ní Chróinín D, Gaine S. Crack-ing the case: a patient with persistent delirium due to body packing with cocaine. Ir Med J. 2012;105:118–119.
   PubMedGoogle Scholar
• Kundu R, Almasri H, Moza A, et al. Intravenous lipid emulsion in wide complex arrhythmia with alternating bundle branch block pattern from cocaine overdose. Kardiol Pol. 2013;71:1073–1075.
   PubMed Web of Science ®Google Scholar
• McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897–1907.
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64:e139–e228.
   PubMed Web of Science ®Google Scholar
• Michalewicz L, Messerli FH. Cardiac effects of calcium antagonists in systemic hypertension. Am J Cardiol. 1997;79:39–46.
   PubMed Web of Science ®Google Scholar
• Rowbotham MC, Hooker WD, Mendelson J, et al. Cocaine-calcium channel antagonist interactions. Psychopharmacology (Berlin). 1987;93:152–154.
   PubMed Web of Science ®Google Scholar
• Muntaner C, Kumor KM, Nagoshi C, et al. Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology (Berlin). 1991;105:37–41.
   PubMed Web of Science ®Google Scholar
• Negus BH, Willard JE, Hillis LD, et al. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil. Am J Cardiol. 1994;73:510–513.
   PubMed Web of Science ®Google Scholar
• Kosten TR, Woods SW, Rosen MI, et al. Interactions of cocaine with nimodipine: a brief report. Am J Addict. 1999;8:77–81.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Singha A, Kosten TR, et al. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav. 2003;75:801–808.
   PubMed Web of Science ®Google Scholar
• Johnson BA, Wells LT, Roache JD, et al. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. Am J Hypertens. 2005;18:813–822.
   PubMed Web of Science ®Google Scholar
• Hoskins MH, Leleiko RM, Ramos JJ, et al. Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use. J Cardiovasc Pharmacol Ther. 2010;15:47–52.
   PubMed Web of Science ®Google Scholar
• Sand IC, Brody SL, Wrenn KD, et al. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med. 1991;9:161–163.
   PubMed Web of Science ®Google Scholar
• Minor RL Jr, Scott BD, Brown DD, et al. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med. 1991;115:797–806.
   PubMed Web of Science ®Google Scholar
• Nanji AA, Filipenko JD. Asystole and ventricular fibrillation associated with cocaine intoxication. Chest. 1984;85:132–133.
   PubMed Web of Science ®Google Scholar
• Rollingher IM, Belzberg AS, Macdonald IL. Cocaine-induced myocardial infarction. CMAJ. 1986;135:45–46.
   PubMed Web of Science ®Google Scholar
• Zimmerman FH, Gustafson GM, Kemp HG Jr. Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: evidence for coronary artery spasm culminating in thrombosis. J Am Coll Cardiol. 1987;9:964–968.
   PubMed Web of Science ®Google Scholar
• Myers GH, Hansen TH, Jain A. Left main coronary artery and femoral artery vasospasm associated with cocaine use. Chest. 1991;100:257–258.
   PubMed Web of Science ®Google Scholar
• Williams MJ, Stewart RA. Serial angiography in cocaine-induced myocardial infarction. Chest. 1997;111:822–824.
   PubMed Web of Science ®Google Scholar
• Alvarez D, Nzerue CM, Daniel JF, et al. Acute interstitial nephritis induced by crack cocaine binge. Nephrol Dial Transplant. 1999;14:1260–1262.
   PubMed Web of Science ®Google Scholar
• Olson KR. What is the best treatment for acute calcium channel blocker overdose? Ann Emerg Med. 2013;62:259–261.
   PubMed Web of Science ®Google Scholar
• Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e179–e347.
   PubMed Web of Science ®Google Scholar
• Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990;112:897–903.
   PubMed Web of Science ®Google Scholar
• Jacobsen TN, Grayburn PA, Snyder RW II, et al. Effects of intranasal cocaine on sympathetic nerve discharge in humans. J Clin Invest. 1997;99:628–634.
   PubMed Web of Science ®Google Scholar
• Brogan WC III, Lange RA, Kim AS, et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18:581–586.
   PubMed Web of Science ®Google Scholar
• Hollander JE, Hoffman RS, Gennis P, et al. Nitroglycerin in the treatment of cocaine associated chest pain-clinical safety and efficacy. J Toxicol Clin Toxicol. 1994;32:243–256.
   PubMed Web of Science ®Google Scholar
• Tuncel M, Wang Z, Arbique D, et al. Mechanism of the blood pressure-raising effect of cocaine in humans. Circulation. 2002;105:1054–1059.
   PubMed Web of Science ®Google Scholar
• Gutierrez A, England JD, Krupski WC. Cocaine-induced peripheral vascular occlusive disease-a case report. Angiology. 1998;49:221–224.
   PubMed Web of Science ®Google Scholar
• Coleman DL, Ross TF, Naughton JL. Myocardial ischemia and infarction related to recreational cocaine use. West J Med. 1982;136:444–446.
   PubMedGoogle Scholar
• Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 1985;14:1112–1113.
   PubMed Web of Science ®Google Scholar
• Ascher EK, Stauffer JC, Gaasch WH. Coronary artery spasm, cardiac arrest, transient electrocardiographic Q waves and stunned myocardium in cocaine-associated acute myocardial infarction. Am J Cardiol. 1988;61:939–941.
   PubMed Web of Science ®Google Scholar
• Pollan S, Tadjziechy M. Esmolol in the management of epinephrine- and cocaine-induced cardiovascular toxicity. Anesth Analg. 1989;69:663–664.
   PubMed Web of Science ®Google Scholar
• Rummel TS. Cocaine cardiac toxicity. J Tenn Med Assoc. 1989;82:541.
   PubMedGoogle Scholar
• Stenberg RG, Winniford MD, Hillis LD, et al. Simultaneous acute thrombosis of two major coronary arteries following intravenous cocaine use. Arch Pathol Lab Med. 1989;113:521–524.
   PubMed Web of Science ®Google Scholar
• Grewal RP, Miller BL. Cocaine induced hypertensive encephalopathy. Acta Neurol (Napoli). 1991;13:279–281.
   PubMedGoogle Scholar
• Inyang VA, Cooper AJ, Hodgkinson DW. Cocaine induced myocardial infarction. J Accid Emerg Med. 1999;16:374–375.
   PubMedGoogle Scholar
• Shah DM, Dy TC, Szto GY, et al. Percutaneous transluminal coronary angioplasty and stenting for cocaine-induced acute myocardial infarction: a case report and review. Catheter Cardiovasc Interv. 2000;49:447–451.
   PubMed Web of Science ®Google Scholar
• Missouris CG, Swift PA, Singer DR. Cocaine use and acute left ventricular dysfunction. Lancet. 2001;357:1586.
   PubMed Web of Science ®Google Scholar
• Erwin MB, Deliargyris EN. Cocaine-associated chest pain. Am J Med Sci. 2002;324:37–44.
   PubMed Web of Science ®Google Scholar
• Feldhendler M, May JA, Gandhi SD, et al. A triple-lumen aorta: an unusual manifestation of complex aortic pathology associated with crack cocaine abuse. J Cardiothorac Vasc Anesth. 2007;21:462–464.
   PubMed Web of Science ®Google Scholar
• Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557–1562.
   PubMed Web of Science ®Google Scholar
• Menon DV, Wang Z, Fadel PJ, et al. Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans. J Am Coll Cardiol. 2007;50:626–633.
   PubMed Web of Science ®Google Scholar
• Newton TF, De La Garza R II, Brown G, et al. Noradrenergic α1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS One. 2012;7:e30854.
   PubMed Web of Science ®Google Scholar
• Kontak AC, Victor RG, Vongpatanasin W. Dexmedetomidine as a novel countermeasure for cocaine-induced central sympathoexcitation in cocaine-addicted humans. Hypertension. 2013;61:388–394.
   PubMed Web of Science ®Google Scholar
• De La Garza R II, Galloway GP, Newton TF, et al. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine. Prog Neuropsychopharmacol Biol Psychiatry. 2014;50:44–52.
   PubMed Web of Science ®Google Scholar
• Martinez-Quintana E, Jaimes-Vivas R, Cuba-Herrera J, et al. Acute myocardial infarction secondary to catecholamine release owing to cocaine abuse and pheochromocytoma crisis. Int J Endocrinol Metab. 2013;11:48–51.
   PubMedGoogle Scholar
• Hollander JE. Cocaine intoxication and hypertension. Ann Emerg Med. 2008;51:S18–S20.
   PubMed Web of Science ®Google Scholar
• Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation. 2010;122:2558–2569.
   PubMed Web of Science ®Google Scholar
• Vongpatanasin W, Mansour Y, Chavoshan B, et al. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation. 1999;100:497–502.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Brown S, Babb DA, et al. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend. 2000;60:69–76.
   PubMed Web of Science ®Google Scholar
• Sofuoglu M, Brown S, Babb DA, et al. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. Pharmacol Biochem Behav. 2000;65:255–259.
   PubMed Web of Science ®Google Scholar
• Vongpatanasin W, Taylor JA, Victor RG. Effects of cocaine on heart rate variability in healthy subjects. Am J Cardiol. 2004;93:385–388.
   PubMed Web of Science ®Google Scholar
• Orr D, Jones I. Anaesthesia for laryngoscopy. A comparison of the cardiovascular effects of cocaine and lignocaine. Anaesthesia. 1968;23:194–202.
   PubMed Web of Science ®Google Scholar
• Boehrer JD, Moliterno DJ, Willard JE, et al. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993;94:608–610.
   PubMed Web of Science ®Google Scholar
• Dattilo PB, Hailpern SM, Fearon K, et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51:117–125.
   PubMed Web of Science ®Google Scholar
• Mohamad T, Kondur A, Vaitkevicius P, et al. Cocaine-induced chest pain and beta-blockade: an inner city experience. Am J Ther. 2008;15:531–535.
   PubMed Web of Science ®Google Scholar
• Rangel C, Shu RG, Lazar LD, et al. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170:874–879.
   PubMedGoogle Scholar
• Ibrahim M, Maselli DJ, Hasan R, et al. Safety of β-blockers in the acute management of cocaine-associated chest pain. Am J Emerg Med. 2013;31:613–616.
   PubMed Web of Science ®Google Scholar
• Fanari Z, Kennedy KK, Lim MJ, et al. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain. Am J Cardiol. 2014;113:1802–1806.
   PubMed Web of Science ®Google Scholar
• Gupta N, Washam JB, Mountantonakis SE, et al. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry). Am J Cardiol. 2014;113:749–756.
   PubMed Web of Science ®Google Scholar
• Rappolt RT, Gay GR, Inaba DS. Propranolol: a specific antagonist to cocaine. Clin Toxicol. 1977;10:265–271.
   PubMed Web of Science ®Google Scholar
• Meyers EF. Cocaine toxicity during dacryocystorhinostomy. Arch Ophthalmol. 1980;98:842–843.
   PubMedGoogle Scholar
• Nicholson KE, Rogers JE. Cocaine and adrenaline paste: a fatal combination? BMJ. 1995;311:250–251.
   PubMed Web of Science ®Google Scholar
• Gay GR. Letter: Propranolol combats cocaine effects. JACEP. 1976;5:549.
   PubMedGoogle Scholar
• Rappolt RT, Gay G, Inaba DS, Rappolt NR. Propranolo in cocaine toxicity. Lancet. 1976;2:640–641.
   PubMed Web of Science ®Google Scholar
• Rappolt RT Sr, Gay G, Inaba DS, et al. Use of Inderal (propranolol-Ayerst) in I-a (early stimulative) and I-b (advanced stimulative) classification of cocaine and other sympathomimetic reactions. Clin Toxicol. 1978;13:325–332.
   PubMed Web of Science ®Google Scholar
• el-Din AS, Mostafa SM. Severe hypertension during anaesthesia for dacryocystorhinostomy. Anaesthesia. 1985;40:787–789.
   PubMed Web of Science ®Google Scholar
• Dusenberry SJ, Hicks MJ, Mariani PJ. Labetalol treatment of cocaine toxicity. Ann Emerg Med. 1987;16:235
   PubMed Web of Science ®Google Scholar
• Burton KR, Martin CA, Murray FT, et al. Hyperthyroidism in a cocaine-dependent patient. J Clin Psychiatry. 1989;50:305–306.
   PubMed Web of Science ®Google Scholar
• Samuels J, Schwalbe SS, Marx GF. Speedballs: a new cause of intraoperative tachycardia and hypertension. Anesth Analg. 1991;72:397–398.
   PubMed Web of Science ®Google Scholar
• Malbrain ML, Neels H, Vissers K, et al. A massive, near-fatal cocaine intoxication in a body-stuffer. Case report and review of the literature. Acta Clin Belg. 1994;49:12–18.
   PubMed Web of Science ®Google Scholar
• Singh PP, Dimich I, Shamsi A. Intraoperative pulmonary oedema in a young cocaine smoker. Can J Anaesth. 1994;41:961–964.
   PubMed Web of Science ®Google Scholar
• Williams RG, Kavanagh KM, Teo KK. Pathophysiology and treatment of cocaine toxicity: implications for the heart and cardiovascular system. Can J Cardiol. 1996;12:1295–1301.
   PubMed Web of Science ®Google Scholar
• Laffey JG, Neligan P, Ormonde G. Prolonged perioperative myocardial ischemia in a young male: due to topical intranasal cocaine? J Clin Anesth. 1999;11:419–424.
   PubMed Web of Science ®Google Scholar
• Ortega-Carnicer J, Bertos-Polo J, Gutiérrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrrhythmias after massive cocaine ingestion. J Electrocardiol. 2001;34:345–349.
   PubMed Web of Science ®Google Scholar
• Mégarbane B, Ekhérian JM, Couchard AC, et al. Surgery to save body-packers. Ann Fr Anesth Reanim. 2004;23:495–498.
   PubMedGoogle Scholar
• Izquierdo Gómez MM, Domínguez-Rodríguez A, Gálvez Rodríguez M, et al. Reflections on beta-adrenergic receptor blockers and cocaine use. A case in point. Rev Esp Cardiol. 2009;62:455–456.
   PubMed Web of Science ®Google Scholar
• Öcal L, Çakir H, Tellice M, et al. Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy. Herz. 2015;40:159–161.
   PubMed Web of Science ®Google Scholar
• Leikin JB. Cocaine and beta-adrenergic blockers: a remarriage after a decade-long divorce? Crit Care Med. 1999;27:688–689.
   PubMed Web of Science ®Google Scholar
• Page RL II, Utz KJ, Wolfel EE. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome? Ann Pharmacother. 2007;41:2008–2013.
   PubMed Web of Science ®Google Scholar
• Finkel JB, Marhefka GD. Rethinking cocaine-associated chest pain and acute coronary syndromes. Mayo Clin Proc. 2011;86:1198–1207.
   PubMed Web of Science ®Google Scholar
• Mariani PJ. Beta-blockers following cocaine use: a reappraisal. Ann Emerg Med. 2008;52:89 author reply 89–90.
   PubMed Web of Science ®Google Scholar
• Schurr JW, Gitman B, Belchikov Y. Controversial therapeutics: the β-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma. Pharmacotherapy. 2014;34:1269–1281.
   PubMed Web of Science ®Google Scholar
• Vergara-Moragues E, Araos Gómez P, González-Saiz F, et al. Cocaine-induced psychotic symptoms in clinical setting. Psychiatry Res. 2014;217:115–120.
   PubMed Web of Science ®Google Scholar
• Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol. 2008;23 Suppl 1:15–26.
   PubMed Web of Science ®Google Scholar
• Sherer MA, Kumor KM, Jaffe JH. Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res. 1989;27:117–125.
   PubMed Web of Science ®Google Scholar
• Walsh SL, Preston KL, Sullivan JT, et al. Fluoxetine alters the effects of intravenous cocaine in humans. J Clin Psychopharmacol. 1994;14:396–407.
   PubMed Web of Science ®Google Scholar
• Winther LC, Saleem R, McCance-Katz EF, et al. Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects. Am J Drug Alcohol Abuse. 2000;26:47–59.
   PubMed Web of Science ®Google Scholar
• Stoops WW, Lile JA, Lofwall MR, et al. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. Am J Drug Alcohol Abuse. 2007;33:769–776.
   PubMed Web of Science ®Google Scholar
• Lile JA, Stoops WW, Hays LR, et al. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. Am J Drug Alcohol Abuse. 2008;34:721–729.
   PubMed Web of Science ®Google Scholar
• Lile JA, Stoops WW, Glaser PE, et al. Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacol. 2011;25:1469–1479.
   PubMed Web of Science ®Google Scholar
• Cox RD, Koelliker DE, Bradley KG. Association between droperidol use and sudden death in two patients intoxicated with illicit stimulant drugs. Vet Hum Toxicol. 2004;46:21–23.
   PubMedGoogle Scholar
• Henderson JB, Labbate L, Worley M. A case of acute dystonia after single dose of aripiprazole in a man with cocaine dependence. Am J Addict. 2007;16:244.
   PubMed Web of Science ®Google Scholar
• Saland KE, Hillis LD, Lange RA, et al. Influence of morphine sulfate on cocaine-induced coronary vasoconstriction. Am J Cardiol. 2002;90:810–811.
   PubMed Web of Science ®Google Scholar
• Shih RD, Hollander JE, Burstein JL, et al. Clinical safety of lidocaine in patients with cocaine-associated myocardial infarction. Ann Emerg Med. 1995;26:702
   PubMed Web of Science ®Google Scholar
• Lormans P, Gaumann D, Schwieger I, et al. Ventricular fibrillation following local application of cocaine and epinephrine for nasal surgery. ORL J Otorhinolaryngol Relat Spec. 1992;54:160–162.
   PubMed Web of Science ®Google Scholar
• Wang T, Hadidi F, Triana F, et al. Myocardial infarction associated with the use of cocaine. Am J Med Sci. 1988;295:569–571.
   PubMed Web of Science ®Google Scholar
• Hunter R. Ventricular tachycardia following naloxone administration in an illicit drug misuse. J Clin Forensic Med. 2005;12:218–219.
   PubMedGoogle Scholar
• Grigorov V, Goldberg L, Foccard JP. Cardiovascular complications of acute cocaine poisoning: a clinical case report. Cardiovasc J S Afr. 2004;15:139–142.
   PubMedGoogle Scholar
• Irani F, Kasmani R, Kanjwal Y. Hyperkalemia and cocaine induced dynamic Brugada-type electrocardiogram. Eur J Emerg Med. 2010;17:113–115.
   PubMed Web of Science ®Google Scholar
• Jakkala-Saibaba R, Morgan PG, Morton GL. Treatment of cocaine overdose with lipid emulsion. Anaesthesia. 2011;66:1168–1170.
   PubMed Web of Science ®Google Scholar
• Arora NP, Berk WA, Aaron CK, et al. Usefulness of intravenous lipid emulsion for cardiac toxicity from cocaine overdose. Am J Cardiol. 2013;111:445–447.
   PubMed Web of Science ®Google Scholar